About Bio-Path
Overview
Leadership
Scientifc Advisory Board
Directors
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us
SEC Form 8-K: Press Release dated August 21, 2024
BPTH__20240821_8-K
SEC Form 8-K: Press Release dated August 15, 2024
BPTH_20240815_8-K
SEC Form 10-Q for period ending June 30, 2024
BPTH_2nd_Qtr_20240814_10-Q
SEC Form 8-K: Press Release dated July 8, 2024
BPTH_8-K_07112024
SEC Form 8-K: Press Release dated June 14, 2024
BPTH_Form_8-K_06-14-24_Press_Release
SEC Form 424b3 Prospectus – June 14, 2024
BPTH_Prospectus_Resale_June_2024_PIPE
Download
SEC Form 8-K: re Nasdaq Extension
BPTH_Form_8-K_Nasdaq-Extension
SEC Form S-3
BPTH_Form_S-3_Resale_Registration_Statement_20240611_PIPE
SEC Form 8-K: Press Release dated June 5, 2024
BPTH_8-K_20240605
SEC Form 8-K: Press Release dated June 3, 2024
BPTH_20240602_8-K
About Bio-Path
Overview
Leadership
Scientifc Advisory Board
Directors
Partnering Opportunities
Technology
Pipeline
Pipeline
Prexigebersen
BP1001-A
BP1002
BP1003
Patients
Investors
Overview
SEC Filings
Corporate Governance
Media
Press Releases
Events
Presentations & Publications
Careers
Contact Us